References

expand symbol  Uniform Data Set v3.0

  • Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzhemers Dement, 7(3):270-279, 2011. DOI: 10.1016/j.jalz.2011.03.008
  • Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18):1789-1799, 2007. DOI: 10.1212/01.WNL.0000287431.88658.8b
  • Armstrong, MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5):496-503, 2013. DOI: 10.1212/WNL.0b013e31827f0fd1
  • Benison G, Ludolph A, Agid Y, et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain, 132(Pt 1):156-171, 2009. DOI: 10.1093/brain/awn291
  • Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1(5):293-299, 2000. DOI: 10.1080/146608200300079536
  • Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord, 13(S3):2–23, 1998. DOI: 10.1002/mds.870131303
  • Ferman TJ, Boeve BF, Smith GE, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology, 77(9):875-882, 2011. DOI: 10.1212/WNL.0b013e31822c9148
  • Ferman TJ, Smith GE, Boeve BF, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. Clin Neuropsychol, 20(4):623-636, 2006. DOI: 10.1080/13854040500376831
  • Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia, 55(4):475-482, 2014. DOI: 10.1111/epi.12550
  • Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol, 1(7):426-436, 2002. DOI: 10.1016/S1474-4422(02)00190-4
  • Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71(9):670-676, 2008. DOI: 10.1212/01.wnl.0000324625.00404.15
  • Ivanova I, Salmon DP, Gollan TH. The multilingual naming test in Alzheimer's disease: clues to the origin of naming impairments. J Int Neuropsychol Soc, 19(3):272-283, 2013. DOI: 10.1017/S1355617712001282
  • Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 18(5):467-486, 2003. DOI: 10.1002/mds.10459
  • Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke, 27(8):1274-1282, 1996. DOI: 10.1161/01.STR.27.8.1274
  • McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol, 68(7):709-735, 2009. DOI: 10.1097/NEN.0b013e3181a9d503
  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and Management of Dementia with Lewy Bodies: Third report of the DLB Consortium. Neurology, 65(12):1863-1872, 2005. DOI: 10.1212/01.wnl.0000187889.17253.b1
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement, 7(3):263-269, 2011. DOI: 10.1016/j.jalz.2011.03.005
  • Menon DK, Schwab K, Wright DW, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil, 91(11):1637-1640, 2010. DOI: 10.1016/j.apmr.2010.05.017
  • Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11):2412-2414, 1993. DOI: 10.1212/WNL.43.11.2412-a
  • Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4):695-699, 2005. DOI: 10.1111/j.1532-5415.2005.53221.x
  • Pfeffer RI, Kurosaki TT, Harrah CH, et al. Measurements of functional activities of older adults in the community. J Gerontol, 37(3):323-329, 1982. DOI: 10.1093/geronj/37.3.323
  • Possin KL, Laluz VR, Alcantar OZ, et al. Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia. Neuropsychologia, 49(1):43-48, 2011. DOI: 10.1016/j.neuropsychologia.2010.10.026
  • Puoti G1, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol, 11(7):618-628, 2012. DOI: 10.1016/S1474-4422(12)70063-7
  • Crutch SJ, Schott JM, Rabinovici GD, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement, 9(4):463-465, 2013. DOI: 10.1016/j.jalz.2012.11.004
  • Rossetti HC, Lacritz LH, Cullum CM, et al. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology; 77(13):1272-1275, 2011. DOI: 10.1212/WNL.0b013e318230208a
  • Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention 165–173, NY: The Haworth Press, 1986.
  • Shirk SD, Mitchell MB, Shaughnessy LW, et al. A web-based normative calculator for the Uniform Data Set (UDS) neuropsychological test battery. Alzheimers Res Ther, 3(6):32, 2011. DOI: 10.1186/alzrt94
  • Stern RA, Daneshvar DH, Baugh CM, et al. Clinical presentation of chronic traumatic encephalopathy. Neurology, 81(13):1122-1129, 2013. DOI: 10.1212/WNL.0b013e3182a55f7f
  • Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol, 12(8):822-838, 2013. DOI: 10.1016/S1474-4422(13)70124-8
  • Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychological test battery. Alzheimer Dis Assoc Disord, 23(2):91-101, 2009. DOI: 10.1097/WAD.0b013e318191c7dd

expand symbol  Uniform Data Set v2.0

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ, 58(1):113-130, 1980. PMCID: PMC2395897
  • Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord, 21(3):249-258, 2007. DOI: 10.1097/WAD.0b013e318142774e
  • Fahn S, Elton R. UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S MC, Calne DB, Goldstein M, ed. Recent developments in Parkinson's disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
  • Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. 2nd ed. Philadelphia: Lea and Febiger, PRO-ED Inc; 1983.
  • Kukull WA, Larson EB, Teri L, et al. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J Clin Epidemiol, 47(9):1061-1067, 1994. DOI: 10.1016/0895-4356(94)90122-8
  • Kumar R, Bergeron C, Pollanen M, Lang A. Cortical basal ganglionic degeneration. In: Jankovic J TE, ed. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1998:297-316.
  • Lang A, Riley D, Bergeron C. Cortico-basal ganglionic degeneration. In: DB C, ed. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994:877-894.
  • Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47(1):1-9, 1996. DOI: 10.1212/WNL.47.1.1
  • McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7):939-944, 1984. DOI: 10.1212/WNL.34.7.939
  • Mesulam MM. Primary progressive aphasia. Ann Neurol, 49(4):425-432, 2001. DOI: 10.1002/ana.91
  • Mesulam MM. Primary progressive aphasia--a language-based dementia. N Engl J Med, 349(16):1535-1542, 2003. DOI: 10.1056/NEJMra022435
  • Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord, 20(4):210-216, 2006. DOI: 10.1097/01.wad.0000213865.09806.92
  • Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51(6):1546-1554, 1998. DOI: 10.1212/WNL.51.6.1546
  • Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol, 62(7):1160-1163, 2005. DOI: 10.1001/archneur.62.7.1160
  • Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43(2):250-260, 1993.
  • Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol, 7(5):486-488, 1980. DOI: 10.1002/ana.410070516

expand symbol  FTLD Module

  • Carver CS, White TL, Teri L. Behavioral inhibition, behavioral activation, and effective responses to impending reward and punishment: The BIS/BAS Scales. J Pers Soc Psychol, 67(2):319-333, 1994. http://www.psy.miami.edu/faculty/ccarver/documents/p94_BISBAS.pdf
  • Lennox RD, Wolfe, RN. Revision of the Self-Monitoring Scale. J Pers Socl Psychol, 46(6):1349-1364, 1984. DOI: 10.1037/0022-3514.46.6.1349
  • Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5):496-503, 2013. DOI: 10.1212/WNL.0b013e31827f0fd1
  • Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1(5):293-299, 2000. DOI: 10.1080/146608200300079536
  • Davis M. Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol, 44(1):113-126, 1983. DOI: 10.1037/0022-3514.44.1.113
  • Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology, 76(11):1006-1014, 2011. DOI: 10.1212/WNL.0b013e31821103e6
  • Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 18(5):467-486, 2003. DOI: 10.1002/mds.10459
  • Mesulam MM. Primary progressive aphasia--a language-based dementia. N Engl J Med, 349(16):1535-1542, 2003. DOI: 10.1056/NEJMra022435
  • Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456-2477, 2011. DOI: 10.1093/brain/awr179
  • Rogalsky C, Love T, Driscoll D, et al. Are mirror neurons the basis of speech perception? Evidence from five cases with damage to the purported human mirror system. Neurocase, 17(2):178-187, 2011. DOI: 10.1080/13554794.2010.509318
  • Thompson CK, Lukic S, King MC, et al. Verb and noun deficits in stroke-induced and primary progressive aphasia: The Northwestern Naming Battery(). Aphasiology, 26(5):632-655, 2012. DOI: 10.1080/02687038.2012.676852
  • Weintraub S, Mesulam MM, Wieneke C, et al. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen, 24(5):408-416, 2009. DOI: 10.1177/1533317509343104

expand symbol  Neuropathology Data Set

  • Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol, 117(3):309-320, 2009. DOI: 10.1007/s00401-009-0485-4
  • Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol, 60(4):328-341, 2001. DOI: 10.1093/jnen/60.4.328
  • Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol, 171(1):227-240, 2007. DOI: 10.2353/ajpath.2007.070182
  • Dickson DW. Pick's disease: a modern approach. Brain Patho, 8(2):339-354, 1998. DOI: 10.1111/j.1750-3639.1998.tb00158.x
  • Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol, 246(S2):II6-15, 1999. DOI: 10.1007/BF03161076
  • Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol, 61(11):935-946, 2002. DOI: 10.1093/jnen/61.11.935
  • Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement, (1):1-13, 2012. DOI: 10.1016/j.jalz.2011.10.007
  • Kovacs GG, Majtenyi K, Spina S, et al. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol, 67(10):963-975, 2008. DOI: 10.1097/NEN.0b013e318187a80f
  • Mackenzie IR, Munoz DG, Kusaka H, et al. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol, 121(2):207-218, 2011. DOI: 10.1007/s00401-010-0764-0
  • Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1-4. . DOI: 10.1007/s00401-009-0612-2
  • McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain, 136(Pt 1):43-64, 2013. DOI: 10.1093/brain/aws307
  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12):1863-1872, 2005. DOI: 10.1212/01.wnl.0000187889.17253.b1
  • Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med, 117(2):132-144, 1993.
  • Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol, 123(1):1-11, 2012. DOI: 10.1007/s00401-011-0910-3
  • Olichney JM, Hansen LA, Hofstetter CR, et al. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol, 57(6):869-874, 2000. DOI: 10.1001/archneur.57.6.869
  • Thal DR, Rüb U, Orantes M, et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology, 58(12):1791-1800, 2002. DOI: 10.1212/WNL.58.12.1791
  • Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol, 30(5):637-649, 1991. DOI: 10.1002/ana.410300503